Results 271 to 280 of about 12,220,634 (288)

Update on the Safety of Phosphodiesterase Type 5 Inhibitors for the Treatment of Erectile Dysfunction

Sexual Medicine Reviews, 2018
Faysal Yafi, Ira D Sharlip, Edgardo F Becher   +2 more
exaly  

6-Nitrobenzimidazole derivatives: Potential phosphodiesterase inhibitors: Synthesis and structure–activity relationship

Bioorganic and Medicinal Chemistry, 2012
Fazal Rahim, Muhammad Taha, Zarbad Shāh   +2 more
exaly  

Phosphodiesterase-5 Inhibitors in Cardioprotection

2013
Mahesh Thirunavukkarasu, Murugavel Ponnusamy   +1 more
openaire   +1 more source

Pharmacodynamics, pharmacokinetics and clinical efficacy of phosphodiesterase-5 inhibitors

Expert Opinion on Drug Metabolism and Toxicology, 2017
Isaac Kim
exaly  

CoMFA of benzyl derivatives of 2,1,3-benzo and benzothieno[3,2-a]thiadiazine 2,2-dioxides: clues for the design of phosphodiesterase 7 inhibitors

European Journal of Medicinal Chemistry, 2001
Ana Castro, Ana Martinez, Carmen Gil
exaly  

Towards selective phosphodiesterase 2A (PDE2A) inhibitors: a patent review (2010 - present)

Expert Opinion on Therapeutic Patents, 2016
Andres A Trabanco, Peter Buijnsters, Frederik Rombouts   +2 more
exaly  

1-(2-Ethoxyethyl)-1H-pyrazolo[4,3-d]pyrimidines as potent phosphodiesterase 5 (PDE5) inhibitors

Bioorganic and Medicinal Chemistry Letters, 2010
John Walker, Michael J Palmer, Brian R Bond   +2 more
exaly  

Phosphodiesterase-5 inhibitors for the treatment of Raynaud's: a novel indication

Expert Opinion on Investigational Drugs, 2009
Chris T Derk
exaly  

Nitrates and Phosphodiesterase-5 Inhibitors

JACC
Dimitrios Terentes-Printzios, Stergios Soulaidopoulos, Nikolaos Ioakeimidis, Konstantinos Tsioufis, Charalambos Vlachopoulos   +4 more
openaire   +1 more source

Tyrosyl-DNA phosphodiesterase inhibitors: Progress and potential

Bioorganic and Medicinal Chemistry, 2016
Olga Lavrik, Nariman Salakhutdinov
exaly